Use of short-acting β2-agonists during pregnancy and the risk of pregnancy-induced hypertension

Journal of Allergy and Clinical Immunology

Volumn 119, Issue 3, 2007, Pages 576-582

  Martel, Marie Josée ^a   Rey, Évelyne ^c   Beauchesne, Marie France ^a,d   Perreault, Sylvie ^a   Forget, Amélie ^e   Maghni, Karim ^e   Lefebvre, Geneviève ^b   Blais, Lucie ^a,e  

^a Pharmacy Faculty   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

^d Pharmacy Department

^e HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

administrative databases; Asthma; asthma medications; gestational hypertension; pharmacoepidemiology; preeclampsia; pregnancy; pregnancy induced hypertension; short acting 2 agonists

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; SHORT ACTING DRUG; ANTIASTHMATIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CANADA; CASE CONTROL STUDY; DRUG SAFETY; ECLAMPSIA; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; EPIDEMIOLOGY; INHALATIONAL DRUG ADMINISTRATION; PREGNANCY; RISK;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; COHORT EFFECT; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PREGNANCY; RISK;

EID: 33847333704     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.10.034     Document Type: Article

References (34)

1. National Institutes of Health. Working group report on high blood pressure in pregnancy. National high blood pressure education program report. Report no. 00-3029 (2000), National Institutes of Health, Bethesda (MD)
2. Bahna S.L., and Bjerkedal T. The course and outcome of pregnancy in women with bronchial asthma. Acta Allergol 27 (1972) 397-406
3. Schatz M., Zeiger R.S., Hoffman C.P., Harden K., Forsythe A., Chilingar L., et al. Perinatal outcomes in the pregnancies of asthmatic women: a prospective controlled analysis. Am J Respir Crit Care Med 151 (1995) 1170-1174
4. Martel M.J., Rey E., Beauchesne M.-F., Perreault S., Lefebvre G., Forget A., et al. Use of inhaled corticosteroids during pregnancy and risk of pregnancy induced hypertension: nested case-control study. BMJ 330 (2005) 230-233
5. Bennett J.A., Smyth E.T., Pavord I.D., Wilding P.J., and Tattersfield A.E. Systemic effects of salbutamol and salmeterol in patients with asthma. Thorax 49 (1994) 771-774
6. Kung M., Croley S.W., and Phillips B.A. Systemic cardiovascular and metabolic effects associated with the inhalation of an increased dose of albuterol-influence of mouth rinsing and gargling. Chest 91 (1987) 382-387
7. Bremner P., Woodman K., Burgess C., Crane J., Purdie G., Pearce N., et al. A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol. Eur Respir J 6 (1993) 204-210
8. Crane J., Burgess C., and Beasley R. Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax 44 (1989) 136-140
9. National Asthma Education and Prevention Program expert panel report 2: guidelines for the diagnosis and management of asthma. Report no. 97-4051 (1997), National Institutes of Health, Bethesda (MD)
10. Goodman L.S., Hardman J.G., Limbird L.E., and Gilman A.G. Goodman & Gilman's the pharmacological basis of therapeutics. 10th ed. (2001), McGraw-Hill, New York
11. Liccardi G., D'Amato M., and D'Amato G. Asthma in pregnant patients: pathophysiology and management. Monaldi Arch Chest Dis 53 (1998) 151-159
12. Schatz M., Zeiger R.S., and Claman H.N. Asthma and immunological diseases in pregnancy and early infancy (1998), Marcel Dekker, New York
13. Dombrowski M.P. Pharmacologic therapy of asthma during pregnancy. Obstet Gynecol Clin North Am 24 (1997) 559-574
14. Boulet L.P., Becker A., Berube D., Beveridge R., and Ernst P. Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. CMAJ 161 suppl (1999) S1-S61
15. NAEPP Expert Panel Report. Managing asthma during pregnancy: recommendations for pharmacologic treatment-2004 update. J Allergy Clin Immunol 115 (2005) 34-46
16. Schatz M., Zeiger R.S., Harden K.M., Hoffman C.P., Forsythe A.B., Chilingar L.M., et al. The safety of inhaled beta-agonist bronchodilators during pregnancy. J Allergy Clin Immunol 82 (1988) 686-695
17. Alexander S., Dodds L., and Armson B.A. Perinatal outcomes in women with asthma during pregnancy. Obstet Gynecol 92 (1998) 435-440
18. Schatz M., Dombrowski M.P., Wise R., Momirova V., Landon M., Mabie W., et al. The relationship of asthma medication use to perinatal outcomes. J Allergy Clin Immunol 113 (2004) 1040-1045
19. Cunningham F.G., Leveno K.J., Bloom S.L., Hauth J.C., Gilstrap III L.C., and Wenstrom K.D. Williams obstetrics. 22nd ed. (2005), McGraw-Hill, New York
20. Blais L., Lemiere C., Menzies D., and Berbiche D. Validity of asthma diagnoses recorded in the Medical Services Database of Quebec. Pharmacoepidemiol Drug Saf 15 (2006) 245-252
21. Tamblyn R., Lavoie G., Petrella L., and Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Québec. J Clin Epidemiol 48 (1995) 999-1009
22. Lubin J.H., and Gail M.H. Biased selection of controls for case control analyses of cohort studies. Biometrics 40 (1984) 63-75
23. Helewa M.E., Burrows R.F., Smith J., Williams K., Brain P., and Rabkin S.W. Report of the Canadian Hypertension Society Consensus Conference: 1. definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ 156 (1997) 715-725
24. Blais L., Beauchesne M.-F., and Lévesque S. Socioeconomic status and medication prescription patterns in pediatric asthma in Canada. J Adolesc Health 38 (2006) 607.e9-16
25. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 79 (1989) 340-349
26. Rayburn W.F., Atkinson B.D., Gilbert K., and Turnbull G.L. Short-term effects of inhaled albuterol on maternal and fetal circulations. Am J Obstet Gynecol 171 (1994) 770-773
27. Burggraaf J., Westendorp R.G., in't Veen J.C., Schoemaker R.C., Sterk P.J., Cohen A.F., et al. Cardiovascular side effects of inhaled salbutamol in hypoxic asthmatic patients. Thorax 56 (2001) 567-569
28. Lipworth B.J. Revisiting interactions between hypoxaemia and beta2 agonists in asthma. Thorax 56 (2001) 506-507
29. Clark D.J., and Lipworth B.J. Dose-response of inhaled drugs in asthma. An update. Clin Pharmacokinet 32 (1997) 58-74
30. Zhang J., Klebanoff M.A., Levine R.J., Puri M., and Moyer P. The puzzling association between smoking and hypertension during pregnancy. Am J Obstet Gynecol 181 (1999) 1407-1413
31. Marcoux S., Brisson J., and Fabia J. The effect of cigarette smoking on the risk of preeclampsia and gestational hypertension. Am J Epidemiol 130 (1989) 950-957
32. Blais L., Beauchesne M.-F., Rey E., Malo J.L., and Forget A. Use of inhaled corticosteroids during the first trimester and the risk of congenital malformations among asthmatic pregnant women. Pharmacoepidemiol Drug Saf 13 suppl (2004) S125
33. Van den Brandt P.A., Petri H., Dorant E., Goldbohm R.A., and Van de C.S. Comparison of questionnaire information and pharmacy data on drug use. Pharm Weekbl Sci 13 (1991) 91-96
34. West S.L., Savitz D.A., Koch G., Strom B.L., Guess H.A., and Hartzema A. Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol 142 (1995) 1103-1112